Found: 5
Select item for more details and to access through your institution.
Effect of Three Different Injection Sites on the Pharmacokinetics of the Once-Daily Human GLP-1 Analogue Liraglutide.
- Published in:
- Journal of Clinical Pharmacology, 2011, v. 51, n. 6, p. 951, doi. 10.1177/0091270010374474
- By:
- Publication type:
- Article
Steady state is reached within 2-3 days of once-daily administration of degludec, a basal insulin with an ultralong duration of action 每日1次给予德谷胰岛素(一种持续作用时间超长的基础胰岛素)治疗后在2-3日内可以达到稳态
- Published in:
- Journal of Diabetes, 2016, v. 8, n. 1, p. 132, doi. 10.1111/1753-0407.12266
- By:
- Publication type:
- Article
Influence of Hepatic Impairment on Pharmacokinetics of the Long-Acting Human GLP-1 Analogue Liraglutide.
- Published in:
- Diabetes, 2007, v. 56, p. A145
- By:
- Publication type:
- Article
278-OR: Efficacy and Safety of Anti-interleukin (IL)-21 in Combination with Liraglutide in Adults Recently Diagnosed with Type 1 Diabetes.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-278-OR
- By:
- Publication type:
- Article
PPARγ Pro<sup>12</sup>Ala polymorphism and risk of acute coronary syndrome in a prospective study of Danes.
- Published in:
- BMC Medical Genetics, 2009, v. 10, p. 1, doi. 10.1186/1471-2350-10-52
- By:
- Publication type:
- Article